LISA BRIDWELL: Open Payments
NPI 1902427917 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,102 in 146 payments from 18 companies in 2025. Trend: 2023 $2,685 · 2024 $850 · 2025 $2,102
Food & beverage: $2,102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $414 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $315 |
| Axsome Therapeutics, Inc. | 23 | $279 |
| Lundbeck LLC | 15 | $196 |
| Otsuka America Pharmaceutical, Inc. | 12 | $174 |
| PFIZER INC. | 8 | $168 |
| Alkermes, Inc. | 10 | $143 |
| Vanda Pharmaceuticals Inc. | 5 | $124 |
| Indivior Inc. | 4 | $85 |
| Corium, LLC | 2 | $33 |
Products named: CAPLYTA, REXULTI, Auvelity, VRAYLAR, NURTEC ODT, ARISTADA, SUBLOCADE, HETLIOZ.
Industry payments across IN — which companies pay providers there.
